AKRN Stock Overview
Public Joint Stock Company Acron, together with its subsidiaries, manufactures, distributes, and sells chemical fertilizers and related mineral primary and by-products.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Public Joint Stock Company Acron Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₽18,362.00 |
| 52 Week High | ₽29,700.00 |
| 52 Week Low | ₽7,284.00 |
| Beta | -0.54 |
| 1 Month Change | 0% |
| 3 Month Change | -0.22% |
| 1 Year Change | 138.90% |
| 3 Year Change | 265.49% |
| 5 Year Change | 419.58% |
| Change since IPO | 1,778.37% |
Recent News & Updates
Recent updates
We Think Acron (MCX:AKRN) Can Stay On Top Of Its Debt
Feb 02
Shareholders Would Enjoy A Repeat Of Acron's (MCX:AKRN) Recent Growth In Returns
Dec 22A Look At The Fair Value Of Public Joint Stock Company Acron (MCX:AKRN)
Dec 01Is Acron (MCX:AKRN) A Risky Investment?
Oct 17Acron (MCX:AKRN) Is Reinvesting To Multiply In Value
Sep 10Calculating The Fair Value Of Public Joint Stock Company Acron (MCX:AKRN)
Aug 23Here's Why Acron (MCX:AKRN) Can Manage Its Debt Responsibly
Jun 11Acron's (MCX:AKRN) Returns On Capital Tell Us There Is Reason To Feel Uneasy
May 05What Kind Of Shareholders Own Public Joint Stock Company Acron (MCX:AKRN)?
Feb 22Are Dividend Investors Making A Mistake With Public Joint Stock Company Acron (MCX:AKRN)?
Jan 31
Returns On Capital At Acron (MCX:AKRN) Paint A Concerning Picture
Jan 11Did You Participate In Any Of Acron's (MCX:AKRN) Fantastic 143% Return ?
Dec 21Is Public Joint Stock Company Acron's (MCX:AKRN) 10% ROE Better Than Average?
Dec 03Shareholder Returns
| AKRN | RU Chemicals | RU Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | 0.5% |
| 1Y | 138.9% | -1.6% | 4.4% |
Return vs Industry: AKRN exceeded the Russian Chemicals industry which returned 38.2% over the past year.
Return vs Market: AKRN exceeded the Russian Market which returned -38.2% over the past year.
Price Volatility
| AKRN volatility | |
|---|---|
| AKRN Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 4.7% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in RU Market | 10.0% |
| 10% least volatile stocks in RU Market | 2.5% |
Stable Share Price: AKRN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AKRN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Vladimir Kunitsky | www.acron.ru |
Public Joint Stock Company Acron, together with its subsidiaries, manufactures, distributes, and sells chemical fertilizers and related mineral primary and by-products. The company provides mineral fertilizers, including complex and nitrogen fertilizers; organic compounds comprising methanol, formalin, urea-formaldehyde resins, melamine-urea-formaldehyde resins, and dipping resins; and non-organic compounds, such as low and high density ammonium nitrate, conversion calcium carbonate, liquid carbon dioxide, and urea for diesel exhaust fluid production. It also offers rare earth elements (REE) from apatite concentrate process flows consisting of cerium, lanthanum, neodymium, and didymium, as well as concentrates of light, medium, and heavy REE; and apatite concentrate and ammonia.
Public Joint Stock Company Acron Fundamentals Summary
| AKRN fundamental statistics | |
|---|---|
| Market cap | ₽674.93b |
| Earnings (TTM) | ₽58.23b |
| Revenue (TTM) | ₽170.99b |
11.6x
P/E Ratio3.9x
P/S RatioIs AKRN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AKRN income statement (TTM) | |
|---|---|
| Revenue | ₽170.99b |
| Cost of Revenue | ₽68.40b |
| Gross Profit | ₽102.59b |
| Other Expenses | ₽44.36b |
| Earnings | ₽58.23b |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.58k |
| Gross Margin | 60.00% |
| Net Profit Margin | 34.06% |
| Debt/Equity Ratio | 79.1% |
How did AKRN perform over the long term?
See historical performance and comparison